PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 12941322-3 2003 Target acylsulfonamides were prepared in two steps from commercially available primary sulfonamides, which were selected based on in silico screening for their potential ability to interact with one of three binding surfaces proximal to the PTP1B catalytic site. Sulfonamides 11-23 protein tyrosine phosphatase non-receptor type 1 Homo sapiens 241-246 20410637-0 2010 Sulphonamides as inhibitors of protein tyrosine phosphatase 1B: a three-dimensional quantitative structure-activity relationship study using self-organizing molecular field analysis approach. Sulfonamides 0-13 protein tyrosine phosphatase non-receptor type 1 Homo sapiens 31-62 20410637-3 2010 A three-dimensional quantitative structure-activity relationship (3D-QSAR) study has been performed on a novel class of sulphonamides using self-organizing molecular field analysis (SOMFA) to correlate their chemical structures with their observed PTP 1B inhibitory activities. Sulfonamides 120-133 protein tyrosine phosphatase non-receptor type 1 Homo sapiens 248-254 18372175-0 2008 PTP1B inhibitors: synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffold. Sulfonamides 94-105 protein tyrosine phosphatase non-receptor type 1 Homo sapiens 0-5 16789735-2 2006 An X-ray cocrystal structure of inhibitor 46/PTP1B at 1.8 A resolution demonstrated that the benzimidazole sulfonamides form a bidentate H bond to Asp48 as designed, although the aryl group of the sulfonamide unexpectedly interacts intramolecularly in a pi-stacking manner with the benzimidazole. Sulfonamides 107-118 protein tyrosine phosphatase non-receptor type 1 Homo sapiens 45-50 30743173-0 2019 Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors. Sulfonamides 97-108 protein tyrosine phosphatase non-receptor type 1 Homo sapiens 139-145 16046123-0 2005 Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors. Sulfonamides 56-68 protein tyrosine phosphatase non-receptor type 1 Homo sapiens 79-84